Skip to content

Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy

Endoscopic Treatment of Recurrent Upper GI Bleeding From Gastroduodenal Ulcers: OTSC [Over the Scope Clip] Versus Standard Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01836900
Acronym
STING
Enrollment
64
Registered
2013-04-22
Start date
2013-03-31
Completion date
2015-04-30
Last updated
2013-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Upper Gastrointestinal Hemorrhage

Keywords

OTSC, Upper gastrointestinal bleeding

Brief summary

Prospective-randomized trial. Patients with recurrent bleeding from gastroduodenal ulcers are randomized into either endoscopic treatment with the OTSC \[Over The Scope Clip\] or endoscopic standard therapy. Hypothesis: Endoscopic therapy with OTSC is superior to standard therapy regarding technical success and rebleeding.

Interventions

Hemostasis with Standard Therapy (standard clip or thermal therapy + injection of adrenaline solution) or by application of the Over The Scope Clip and injection of adrenaline solution

Sponsors

University Hospital Tuebingen
CollaboratorOTHER
University Hospital Augsburg
CollaboratorOTHER
Marienkrankenhaus Frankfurt
CollaboratorOTHER
Klinikum Stadt Hanau
CollaboratorOTHER
Klinikum Garmisch-Patenkirchen
CollaboratorOTHER
University of Zurich
CollaboratorOTHER
Universitätsklinikum Hamburg-Eppendorf
CollaboratorOTHER
Kliniken Ludwigsburg-Bietigheim gGmbH
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recurrence of bleeding from gastroduodenal ulcers

Exclusion criteria

* Malignant ulcers, variceal bleeding, patients younger than 18 years, lesions not suitable for treatment with OTSC

Design outcomes

Primary

MeasureTime frame
Persistent bleeding or Rebleeding with 7 days7 days

Secondary

MeasureTime frame
duration of hospital stay30 days
duration of intensive care unit stay30 days
30 d Mortality30 days
blood units transfused30 days
Necessity of surgical or angiographic therapy7 d
Complications during or after OTSC (Over The Scope Clip) placement7 d
Amount of endoscopic reinterventions7 d

Countries

Germany

Contacts

Primary ContactKarel Caca, Prof. Dr.
karel.caca@kliniken-lb.de+49714167201
Backup ContactArthur Schmidt, Dr.
arthur.schmidt@kliniken-lb.de+49714167201

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026